267 related articles for article (PubMed ID: 19740371)
1. Cathepsin D activity protects against development of type AA amyloid fibrils.
van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
[TBL] [Abstract][Full Text] [Related]
2. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
[TBL] [Abstract][Full Text] [Related]
3. Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.
Hol PR; van Ederen AM; Snel FW; Langeveld JP; Veerkamp JH; Gruys E
Br J Exp Pathol; 1985 Jun; 66(3):279-92. PubMed ID: 2860918
[TBL] [Abstract][Full Text] [Related]
4. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
5. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
Westermark GT; Sletten K; Grubb A; Westermark P
Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
[TBL] [Abstract][Full Text] [Related]
6. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid.
Kluve-Beckerman B; Manaloor JJ; Liepnieks JJ
Arthritis Rheum; 2002 Jul; 46(7):1905-13. PubMed ID: 12124875
[TBL] [Abstract][Full Text] [Related]
7. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation.
Yamada T; Kluve-Beckerman B; Liepnieks JJ; Benson MD
Scand J Immunol; 1995 Jun; 41(6):570-4. PubMed ID: 7770727
[TBL] [Abstract][Full Text] [Related]
8. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis.
Phipps-Yonas H; Pinard G; Ali-Khan Z
Scand J Immunol; 2004 Feb; 59(2):168-76. PubMed ID: 14871293
[TBL] [Abstract][Full Text] [Related]
9. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
Arai K; Miura K; Baba S; Shirasawa H
J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
[TBL] [Abstract][Full Text] [Related]
10. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
[TBL] [Abstract][Full Text] [Related]
11. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
Miura K; Ju ST; Cohen AS; Shirahama T
J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
[TBL] [Abstract][Full Text] [Related]
15. Temperature-induced dissociation of serum amyloid protein SAA.
Linke RP
Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):255-61. PubMed ID: 85376
[TBL] [Abstract][Full Text] [Related]
16. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis.
Röcken C; Fändrich M; Stix B; Tannert A; Hortschansky P; Reinheckel T; Saftig P; Kähne T; Menard R; Ancsin JB; Bühling F
J Pathol; 2006 Dec; 210(4):478-87. PubMed ID: 17068745
[TBL] [Abstract][Full Text] [Related]
18. 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils.
Caspi D; Baltz ML; Feinstein A; Munn EA; Pepys MB
Clin Exp Immunol; 1984 Sep; 57(3):647-56. PubMed ID: 6467683
[TBL] [Abstract][Full Text] [Related]
19. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
